VALPROIC ACID (valproic acid) by AbbVie is tract. Approved for women, women of childbearing potential, epilepsy and 5 more indications. First approved in 1986.
Drug data last refreshed 20h ago
tract. The mechanisms by which valproate exerts its therapeutic effects have not been established. It has been suggested that its activity in epilepsy is related to increased brain concentrations of gamma-aminobutyric acid (GABA).
Anti-epileptic Agent
Worked on VALPROIC ACID at AbbVie? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Valproic AcId for Traumatic BRAin INjury Trial
A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants
Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients
Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074